Recurrent rosai-dorfman-destombes disease

Clinical trials for Recurrent rosai-dorfman-destombes disease explained in plain language.

Never miss a new study

Get alerted when new Recurrent rosai-dorfman-destombes disease trials appear

Sign up with your email to follow new studies for Recurrent rosai-dorfman-destombes disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill Q702 aims to outsmart blood cancers in early trial

Disease control Recruiting now

This early-stage trial is testing a new drug called Q702 in people with various blood cancers and related disorders that have not responded to standard treatments. Q702 is designed to help the immune system attack cancer cells and help the bone marrow make healthy blood cells. Th…

Matched conditions: RECURRENT ROSAI-DORFMAN-DESTOMBES DISEASE

Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

Recurrent rosai-dorfman-destombes disease

Get alerted when new Recurrent rosai-dorfman-destombes disease trials appear

New pill Q702 aims to outsmart blood cancers in early trial